Data / Form D filings / ARTELO BIOSCIENCES, INC.
ARTELO BIOSCIENCES, INC.: Form D filings
ARTELO BIOSCIENCES, INC., a biotechnology company in Solana Beach, CA, filed 15 Form D notices with the SEC between 2017 and 2026. The latest, on April 6, 2026, reports $11 million sold of a $11 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 505 LOMAS SANTA FE, SUITE 160, Solana Beach, CA, 92075
- Phone
- (858) 925-7049
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1621221
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | New notice | $10,996,903 | $10,996,903 | 2 | Mar 27, 2026 | sec.gov | |
| Mar 27, 2026 | New notice | $315,000 | $315,000 | 1 | Mar 20, 2026 | sec.gov | |
| Mar 27, 2026 | New notice | $113,000 | $113,000 | 1 | Mar 12, 2026 | sec.gov | |
| Mar 27, 2026 | New notice | $237,300 | $237,300 | 1 | Mar 12, 2026 | sec.gov | |
| Feb 6, 2026 | New notice | $50,500,000 | $500,000 | $50,000,000 | 1 | Jan 30, 2026 | sec.gov |
| Nov 10, 2025 | New notice | $3,718,121 | $3,718,121 | 14 | Oct 28, 2025 | sec.gov | |
| Aug 13, 2025 | New notice | $9,475,000 | $9,475,000 | 18 | Aug 5, 2025 | sec.gov | |
| Jul 9, 2025 | New notice | $1,425,000 | $1,425,000 | 8 | Jun 26, 2025 | sec.gov | |
| May 20, 2022 | New notice | $20,096,972 | $96,972 | $20,000,000 | 1 | May 13, 2022 | sec.gov |
| May 18, 2020 | New notice | $55,000 | $55,000 | 2 | May 4, 2020 | sec.gov | |
| Jun 4, 2019 | New notice | $1,950,000 | $857,430 | $1,092,570 | 59 | Apr 25, 2019 | sec.gov |
| Jun 4, 2019 | New notice | $10,000,000 | $4,192,990 | $5,807,010 | 40 | Jan 8, 2019 | sec.gov |
| Sep 14, 2018 | New notice | $1,125,000 | $525,824 | $599,176 | 24 | Jul 31, 2018 | sec.gov |
| Apr 6, 2018 | New notice | $975,000 | $850,786 | $124,214 | 27 | Mar 23, 2018 | sec.gov |
| Jun 5, 2017 | New notice | $1,000,000 | $0 | $1,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gregory D. Gorgas | Executive Officer, Director | |
| Connie Matsui | Director | |
| Douglas Blayney | Director | |
| Steven Kelly | Director | |
| R. Martin Emanuele | Director | |
| Tamara A. Favorito | Director | |
| Gregory R. Reyes | Director | |
| Mark Spring | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Apr 6, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ARTELO BIOSCIENCES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.